Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging viral diseases and infectious disease risks.

M L Tapper1

  • 1Division of Infectious Diseases and Hospital, Epidemiology, Lenox Hill Hospital, New York, NY 10021, USA. mtapper@lenoxhill.net

Haemophilia : the Official Journal of the World Federation of Hemophilia
|February 1, 2006
PubMed
Summary

Emerging infectious diseases, like avian influenza and SARS, pose global health threats. Vigilance and rapid data sharing are crucial for detecting and controlling novel pathogens to prevent widespread outbreaks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tuberculosis control in health care.

Infection control and hospital epidemiology·1996
Same author

Where are we in tuberculosis infection control?

Infection control and hospital epidemiology·1995
Same author

AIDS 92/93. Clinical treatment: overview.

AIDS (London, England)·1993
Same author

Blastomycosis in patients with the acquired immunodeficiency syndrome.

Annals of internal medicine·1992
Same author

Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome.

JAMA·1990
Same author

Successful prophylaxis of Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole in AIDS patients with previous allergic reactions.

Journal of acquired immune deficiency syndromes·1989

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Emerging and re-emerging pathogens, including antimicrobial-resistant strains, present significant global health risks with potential for high morbidity and mortality.
  • Factors influencing pathogen emergence include vector interactions, microbiological adaptation, global travel, animal contact, and human behavioral changes.
  • Outbreaks of novel pathogens like avian influenza, West Nile virus (WNV), and severe acute respiratory syndrome (SARS) coronavirus highlight current concerns.

Framework:

  • Effective containment of emerging pathogens is often hindered by insufficient or inadequate data.
  • Pathogens transmitted via aerosolized droplets, such as avian influenza and SARS, present substantial containment challenges.
  • Development of rapid screening tests for new pathogens like WNV can be time-consuming and may not be fully reliable.

Related Experiment Videos

Implementation:

  • Vigilance in detecting and controlling newly identified infectious threats is paramount.
  • The potential for infectious agents in the blood supply to impact safe transfusion practices, as seen with HIV, necessitates ongoing monitoring.
  • Collaborative efforts between public health agencies and healthcare providers are essential for global outbreak containment.

Implications:

  • Continuous monitoring and rapid response systems are vital for managing emerging infectious diseases.
  • International cooperation is key to preventing the global spread of dangerous pathogens.
  • Protecting public health requires proactive strategies against evolving microbial threats.